NEOLIVER is a research and innovation project co-funded by European Union (EU) Horizon Europe and Swiss State Secretariat for Education to develop world’s first autologous bioprinted liver.
Coordinated by University of Utrecht, twelve consortium members will develop technologies to establish an automated manufacturing line, vascularize the bioprinted liver constructs by a novel strategy and validate them pre-clinically.
Project timing: 1 January 2025 - 31 December 2028
Learn more about NEOLIVER: https://neoliver.eu/
The content published is the sole responsibility of the authors and do not necessarily reflect the opinion of the European Union.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neoliver.eu/
- Keywords
- Regenerative Medicine.
Neoliver Questions
Neoliver's website is https://neoliver.eu/
Neoliver's LinkedIn profile is https://www.linkedin.com/company/neoliver
Neoliver's industry is
Biotechnology Research
Neoliver's top competitors are
Amires,
Regmed Xb,
Strong-Ur,
Regen Biomedical,
Scinus Cell Expansion B.v.,
Cellntec Advanced Cell Systems,
M2m,
Ecap Project,
Phosprint P.c.,
Ku Leuven Kulak.
Neoliver's categories are Biotechnology Research
